rmp-7 and HIV-Infections

rmp-7 has been researched along with HIV-Infections* in 1 studies

Other Studies

1 other study(ies) available for rmp-7 and HIV-Infections

ArticleYear
Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Colloids and surfaces. B, Biointerfaces, 2012, Feb-01, Volume: 90

    This study investigates the capability of methylmethacrylate-sulfopropylmethacrylate (MMA-SPM) nanoparticles (NPs) with grafted RMP-7 (RMP-7/MMA-SPM NPs) to deliver stavudine (D4T), delavirdine (DLV), and saquinavir (SQV) across the blood-brain barrier (BBB). The permeability coefficients of the three drugs across the BBB were evaluated by a co-culture model containing human brain-microvascular endothelial cells and human astrocytes. An increase in the concentration of ammonium persulfate (APS), the polymerization initiator, enhanced the particle size of drug-loaded RMP-7/MMA-SPM NPs. When the concentration of APS was 0.6%, the average particle diameter was smaller than 50 nm. These spherical drug carriers were uniform in size and displayed a dominant topography of discrete hillocks and deep pits in deposited film. Smaller RMP-7/MMA-SPM NPs yielded a larger drug loading efficiency. The order of drug in the loading efficiency and in the particle uptake was, respectively, D4T>DLV>SQV and D4T>SQV>DLV. Endocytosis of RMP-7/MMA-SPM NPs and tight junction mediation can improve the permeability of D4T, DLV, and SQV across the BBB.

    Topics: Ammonium Sulfate; Anti-HIV Agents; Astrocytes; Biological Transport; Blood-Brain Barrier; Bradykinin; Cells, Cultured; Coculture Techniques; Delavirdine; Drug Carriers; Endothelial Cells; HIV; HIV Infections; Humans; Kinetics; Methacrylates; Microscopy, Electron, Scanning; Molecular Targeted Therapy; Nanoparticles; Particle Size; Permeability; Saquinavir; Stavudine

2012